Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Direskeneli

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Rheumatology (Oxford, England)|September 26, 2006
Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?H Direskeneli
Annals of the Rheumatic Diseases|October 17, 2001
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51H Direskeneli
Genetics Research International|February 4, 2014
Innate and Adaptive Responses to Heat Shock Proteins in Behcet's DiseaseH Direskeneli
Advances in Experimental Medicine and Biology|August 16, 2003
ISBD basic research perspectives. A preliminary "outline " for basic research workshop studiesH Direskeneli, A Gül
Rheumatology International|August 10, 2006
Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritisN Inanc, H Direskeneli
Clinical and Experimental Rheumatology|January 20, 2004
The role of heat shock proteins in Behçet's diseaseH Direskeneli, G Saruhan-Direskeneli
Clinical and Experimental Rheumatology|January 20, 2004
MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvementP Atagunduz, T Ergun, H Direskeneli
The British Journal of Ophthalmology|February 24, 2004
Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndromeE Toker, S Yavuz, H Direskeneli
The Journal of Rheumatology|November 18, 1998
First International Conference on familial Mediterranean fever, Jerusalem, Israel, September 7-11, 1997H Direskeneli, H Ozdogan, H Yazici
Clinical and Experimental Rheumatology|October 24, 2014
Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritisG Ozen, H Direskeneli, N Inanc
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Rheumatology (Oxford, England)|September 26, 2006
Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder?H Direskeneli
Annals of the Rheumatic Diseases|October 17, 2001
Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51H Direskeneli
Genetics Research International|February 4, 2014
Innate and Adaptive Responses to Heat Shock Proteins in Behcet's DiseaseH Direskeneli
Advances in Experimental Medicine and Biology|August 16, 2003
ISBD basic research perspectives. A preliminary "outline " for basic research workshop studiesH Direskeneli, A Gül
Rheumatology International|August 10, 2006
Serious infections under treatment with TNF-alpha antagonists compared to traditional DMARDs in patients with rheumatoid arthritisN Inanc, H Direskeneli
Clinical and Experimental Rheumatology|January 20, 2004
The role of heat shock proteins in Behçet's diseaseH Direskeneli, G Saruhan-Direskeneli
Clinical and Experimental Rheumatology|January 20, 2004
MEFV mutations are increased in Behçet's disease (BD) and are associated with vascular involvementP Atagunduz, T Ergun, H Direskeneli
The British Journal of Ophthalmology|February 24, 2004
Anti-Ro/SSA and anti-La/SSB autoantibodies in the tear fluid of patients with Sjögren's syndromeE Toker, S Yavuz, H Direskeneli
The Journal of Rheumatology|November 18, 1998
First International Conference on familial Mediterranean fever, Jerusalem, Israel, September 7-11, 1997H Direskeneli, H Ozdogan, H Yazici
Clinical and Experimental Rheumatology|October 24, 2014
Cardiovascular risk estimation and management in rheumatoid arthritis: comment on the EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritisG Ozen, H Direskeneli, N Inanc
Pageof 10